Abstract Coronavirus disease 2019 (COVID-19) is a devastating respiratory illness that has
dramatically changed the medical landscape around the world. In parallel with a rise in the …

The combination of cyclophosphamide, vincristine, and prednisone (CVP) is one of several
standard treatment options for advanced follicular lymphoma. This, like similar …

Background A diagnosis of chronic lymphocytic leukemia (CLL) requires a count of over
5000 circulating CLL-phenotype cells per cubic millimeter. Asymptomatic persons with fewer …

Background Dose intensification with a combination of cyclophosphamide, doxorubicin,
vincristine, and prednisolone (CHOP) every 2 weeks improves outcomes in patients older …

Objective There is an increased interest in rheumatology in mesenchymal progenitor/stem
cells (MPCs) and their roles in rheumatic diseases, but little is known about the phenotype of …

We evaluated the role of rituximab (R) both in remission induction and maintenance
treatment of relapsed/resistant follicular lymphoma (FL). A total of 465 patients were …

Purpose Rearrangement of MYC occurs in a proportion of diffuse large B-cell lymphomas
(DLBCL), where they may be associated with an adverse clinical outcome. The aim of this …

The International Prognostic Index (IPI) identifies poor-and good-risk patients with diffuse
large B cell lymphoma (DLBCL); however, the majority of patients have an intermediate IPI …

Unlike their peripheral nervous system counterparts, the capacity of central nervous system
neurons and axons for regeneration after injury is minimal. Although a myriad of therapies …

Molecular and cellular markers associated with malignant disease are frequently identified
in healthy individuals. The relationship between these markers and clinical disease is not …